A carregar...
Management of bone metastases in refractory prostate cancer – role of denosumab
This article reviews the problem of bone disease in prostate cancer and the evolving role of the novel agent denosumab, a fully human monoclonal antibody that inhibits the receptor activator of nuclear factor-κB ligand, in suppressing bone resorption and offering bone protection in this disease. Pro...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3459574/ https://ncbi.nlm.nih.gov/pubmed/23049248 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CIA.S27930 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|